Australian Regulator Pays Pan Pharmaceuticals AU$55m
The following article, which I am delighted to bring to you, is again somewhat off-topic as it has little to do with prostate cancer or even cancer in general, other than perhaps, illustrating once again, just how the heavy hand of officialdom can, and does, use its powers to deny chronically ill patients, and others, access to vitamins and natural medicines.
That Australia’s Therapeutic Goods Administration (TGA) should go to such an extreme as to close down the principal manufacturer and supplier of natural supplements in the country is very questionable. What was the true motive behind their unconscionable - over-the-top - action? Was it simply bureaucracy gone mad? Or was there something more sinister? Like Big Pharma pulling strings, using all its power and influence to further its own ends in the ultimate destruction of the natural health industry? We will have to await the judges summing up to find out.
Australian regulator pays Pan $55m after recall rethink
By Shane Starling
18-Aug-2008 -
The Australian Therapeutic Goods Administration (TGA) will pay $55 million (€32.58m) to liquidated supplements manufacturer Pan Pharmaceuticals after inappropriately recalling the company’s entire 1600-product suite in 2003.
The parties gave evidence to a Federal Court hearing and agreed on the settlement, which the court ratified.
You can find the full report at:






















